Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep250 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Gestational diabetes in korea: Temporal trends in prevalence, treatment, and short-term consequences from a national health insurance claims database 2012 – 2016

Jung Chan-Hee , Mok Ji-Oh , Jung Sang-Hee

Aims: This population-based cross-sectional study aimed to investigate the recent trends in the prevalence and treatment of gestational diabetes mellitus (GDM) in a nationally representative sample of Korean patients. We also investigated trends of annual prevalence rate of pregnancy-induced hypertension (PIH) and cesarean section (C-section) in patients with GDM.Methods: We used data from the Health Insurance Review and Assessment-National Patient Sampl...

ea0070aep422 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

The associations between adipocytokines and future vascular complications in type 2 diabetes

Mok Ji-Oh , Jung Chan-Hee , Kang Sung-Koo

Aims/Introduction: It is thought that adipocytokines contribute to the increased riskof vascular complications in type 2 diabetes (T2DM). However, some data indicate that adipocytokines may protect against cardiovascular disease. The net effects of adipocytokines on vascular pathology are complex and not completely understood. Although previous our cross-sectional studies showed that adipocytokines such as adiponectin, leptin, and TNF-alfa were associated with vascular complic...

ea0056gp85 | Diabetes Epidemiology | ECE2018

Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus

Mok Ji Oh , Jung Chan Hee , Lee Ki Young

Objective: Although the importance of islet α-cell dysfunction in the pathogenesis of type 2 diabetes has been reappraised, data on whether increase or decrease of glucagon relative to insulin is related with glucose metabolism parameters or metabolic diseases such as nonalcoholic fatty liver disease(NAFLD) in clinical settings are very limited. Therefore, we investigated the association between glucagon-to-insulin ratio(G/I ratio) and presence of NAFLD and metabolic para...

ea0063gp203 | Diabetes: Pharmacotherapy | ECE2019

Effects of cardiovascular function of SGLT-2 inhibitos versus DPP–4 inhibitors in type 2 diabetes with coronary artery disease

Kim Chong Hwa , Jung Su Jin , Mok Ji Oh , Lee Ki Young , Kim Sung Rae

Objective: Randomized trials demonstrated a lower risk of cardiovascular (CV) events with sodium – glucose cotransporter-2 inhibitors (SGLT-2i) in patients with type 2 diabetes(T2D) at high CV risk. SGLT2-i should be considered as a valuable therapy in T2D with established atherosclerotic cardiovascular disease (ASCVD) or heart failure (HF). We analyzed the effects of cardiovascular function of SGLT 2 inhibitors in T2D with ASCVD or HF compared with dipeptidyl peptidase-4...

ea0037ep443 | Diabetes (complications & therapy) | ECE2015

Impact on quality of life in peoples with painful diabetic peripheral neuropathy

Kim Chong Hwa , Jeong Su Jin , Mok Ji Oh , Lee Ki Young , Kim Sung Rae

Objective: This study was performed to determine the impact on quality of life and sleep impairment of painful diabetic peripheral neuropathy (PDPN).Research design and method: The study pool consisted of 200 randomly selected peoples with type 2 diabetic peripheral neuropathy. PDPN was diagnosed using visual analogue scales (VAS) and medical history. The patients were asked to answer the Brief Pain Inventory-Short Form (BPI-SF), Medical Outcomes Study S...

ea0037ep849 | Thyroid cancer | ECE2015

Recurrent bone metastasis of follicular thyroid carcinoma with unknown primary site

Mok Ji Oh , Kim Chong Hwa , Kim Sung Rae , Yu Seung Hee , Lee Kiyoung

Introduction: Occurrence of follicular thyroid carcinoma (FTC) is limited almost within thyroid gland, but distant metastasis is discovered uncommonly as first presentation. We experienced a rare case about recurrent bone metastasis of FTC with unknown primary site.Case report: A 58-year-old woman complained about back pain for 3 years. A 5 cm sized mass in right 8th posterior rib was discovered and performed resection. The result of pathology was bone m...

ea0056p500 | Diabetes therapy | ECE2018

Efficacy of glucose control on a combination of dapagliflozin in people with type 2 diabetes mellitus in Korea

Kim Chong Hwa , Mok Ji Oh , Lee Ki Young , Kim Sung Rae

Objective: Dapagliflozin, sodium-glucose cotransporter-2 (SGLT-2) inhibitor, reduces hyperglycemia and body weight by inhibiting renal glucose reabsorption. However, only a few studies have shown the glycemic efficacy on a combination of dapagliflozin in type 2 diabetic patients in Korean. We evaluated the efficacy and safety of glucose control on a combination of dapagliflozin in people with type 2 diabetes in Korea.Methods: This is a retrospective, obs...